Clinical Trials Day: Harvey's Story.
Throughout his time as a patients at both the JR and GW he has been included in clinical research.
Natalie and Thomas' son Harvey was born prematurely – weighing under 800 grams. Throughout his time as a patients at both the JR and GW he has been included in clinical research. One of the research trials that Harvey is enrolled in is looking at adding a nutritional supplement to expressed breast milk to see if it improves cognitive development at 24 months.
DOLFIN is a multicentre blinded randomised placebo-controlled trial. The trial population will be made up of two groups:
Babies born less than 28 weeks of gestation (preterm group)
Babies born at 35 weeks of gestation or more, receiving therapeutic hypothermia for hypoxic ischaemic encephalopathy (HIE group)
The trial aims to recruit 1,010 babies from around 30 neonatal units across the UK.
DOLFIN is taking place between September 2021 and May 2027. Recruitment started in October 2022.
